Track the RGT share price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the authority of ASX. Operating in the Health Care sector, RGT has recorded 2 reports. Market capitalisation: €4.4m. The latest transaction was disclosed on 5 May 2026 (Other). Among the most active insiders: Gary Hermon. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
RGT is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.